BellRing Brands, Inc., a St. Louis-based maker of convenient nutrition products led by its Premier Protein and Dymatize brands, has seen its analyst community sharply reset expectations over the past year. The stock fell from an all-time high near $80 in early 2025 to single digits after a May 2026 earnings miss and a roughly 25% cut to fiscal-year EBITDA guidance.
Reviewing approximately 15 current, attributable targets yields a spread from $9 at Bank of America and TD Cowen to $20 at Evercore ISI and Stephens. The arithmetic mean of these verified targets is about $13.58, which rounds to a central target of $14. Some aggregators show a higher figure near $19 because they still include an older, stale $35 target that was slashed after the May reset; the $9–$20 band reflects the genuinely current outlook.
Ratings are split. Bulls at J.P. Morgan ($18), Evercore ISI ($20), Stifel ($15), and DA Davidson ($15) argue the valuation reset and durable brand equity outweigh near-term margin pain. More cautious voices include Morgan Stanley and Bernstein, which downgraded the stock in May 2026, and UBS, which cut its target to $9.50 in October. BNP Paribas Exane initiated coverage at Outperform with a $12 target in October, signaling selective optimism. The single Sell rating from Bank of America, at $9, underscores how divided the Street remains.
As of the most recently reported close, shares trade near $9.59, toward the lower end of a 52-week range of roughly $7.33 to $35.67. Reaching $14 would require a gain of about 46% — a substantial move, even if modest relative to where the stock traded a year ago.
The path toward the target depends on whether BellRing can stabilize profitability. Revenue has held up — the August 2026 quarter delivered $570.4 million, up 4.2% year over year and above expectations — but EPS (earnings per share) of $0.30 missed the $0.37 consensus estimate. Analysts project roughly $1.03 in EPS for the current fiscal year, down more than 50% from the prior year, reflecting elevated promotions, freight, commodities, and inventory charges.
BellRing's chart shows a stock in a deep downtrend. The 52-week low near $7.33 is the key support level, while the 200-day moving average near $11.50 and the 50-day average near $9.78 sit just above the current price and act as nearby resistance. A sustained move toward $14 would require first reclaiming those moving averages and holding above the psychologically important $10 level.
Analyst price targets generally reflect a roughly 12-month research horizon, and the targets used here span reports issued from May through October 2026. Investors should watch the next earnings release and guidance update, revisions to EBITDA and margin outlook, promotional and commodity-cost trends, any further analyst target changes, and developments in the shareholder investigations. The wide $9–$20 range means any single data point could shift the consensus meaningfully.
For traders tracking whether BRBR can reach its price target, Tickeron's AI Daily Buy/Sell Signals provide an additional layer of analysis. The system uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven evaluation. It is designed to help traders discover opportunities, monitor existing positions, and identify shifting trends more efficiently than manual screening alone.
The $14 central target — the rounded mean of current analyst targets — sits about 46% above the recent price of $9.59 and reflects a stock that has already suffered a dramatic de-rating. Reaching that level is plausible if BellRing executes a margin recovery into FY2027, supported by a discounted valuation, resilient demand, and buybacks. Against that, the persistent EBITDA compression, competitive promotions, cost inflation, and legal overhang all argue for caution, and the wide $9–$20 analyst spread shows the market itself remains divided. Whether the target is reached will depend less on a single quarter and more on evidence that profitability has bottomed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that BRBR and BRCC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BRBR and BRCC's prices will move in lockstep.
| Ticker / NAME | Correlation To BRBR | 1D Price Change % | ||
|---|---|---|---|---|
| BRBR | 100% | +8.49% | ||
| BRCC - BRBR | 33% Poorly correlated | -0.20% | ||
| CENT - BRBR | 27% Poorly correlated | +4.38% | ||
| CENTA - BRBR | 27% Poorly correlated | +4.09% | ||
| SMPL - BRBR | 27% Poorly correlated | +6.58% | ||
| INGR - BRBR | 25% Poorly correlated | +0.60% | ||
More | ||||
| Ticker / NAME | Correlation To BRBR | 1D Price Change % |
|---|---|---|
| BRBR | 100% | +8.49% |
| Food: Major Diversified industry (62 stocks) | 29% Poorly correlated | -2.98% |